Oh, Dong Ryul
Radiation Oncology "Instructor, Department of Radiation Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center" Special Interests : Head and Neck cancer, Esophageal cancer, Lymphoma, Proton therapy
We would like to introduce the details of proton therapy for lymphoma cancer.
If the lymphoma has invaded the mediastinal sites, the application of proton treatment may be considered.
As the prognosis of lymphoma is improved by the enhancement of treatment, reducing the long-term side effects caused by treatment is regarded more importantly.
When applying radiotherapy to mediastinal lymphoma, reducing the radiation dose being transferred to the heart is very important as it can reduce the risks of the heart toxicity, one of the long-term side effects of such treatment. Moreover, reducing the occurrence of secondary cancer by lowering the radiation dose being transferred to organs including the lungs and breasts is important as well.
Proton treatment can contribute to the reduction of heart toxicity and secondary cancer by lowering the transfer range of a medium-low radiation dose. This advantage is expected to be higher in younger patients.
Proton treatment can lower the radiation dose transferred to the vital organs compared to the existing 3-D radiotherapy and intensity modulated radiotherapy.
When implementing the proton treatment, it has been reported that it can be treated safely with lower levels of side effects and that the treatment outcome is outstanding.